Mar 12, 2019 7:30am EDT Nemus Bioscience Confirms NB1111 Mechanism of Action and Reports Positive Results from Glaucoma Biomarker Studies in Human Donor Tissues
Mar 04, 2019 7:30am EST Nemus Bioscience Signs Agreement with Noramco to Manufacture Proprietary Cannabidiol Analog
Feb 14, 2019 7:00am EST Nemus Bioscience Signs Agreement with Pharmaceuticals International Inc. to Develop Dosage Formulation for Human Dosing with NB1111 for Glaucoma
Jan 23, 2019 7:30am EST Nemus Bioscience to Present at the NobleCon XV and 8th Annual Glaucoma 360 New Horizons Forum
Jan 03, 2019 7:00am EST Nemus Bioscience to Present at the 2nd Annual Sach’s Neuroscience Innovation Forum and Biotech Showcase 2019
Nov 29, 2018 3:51pm EST Nemus Bioscience to Present at Investment and Scientific Conferences in December
Oct 08, 2018 8:00am EDT Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20 Million and Adopted an Open Market Share Purchase Program of up to 10 Million Common Shares
